4.4 Article

Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex

期刊

DRUG METABOLISM AND DISPOSITION
卷 46, 期 6, 页码 888-896

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.118.080952

关键词

-

资金

  1. National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) [R01 HD081299]
  2. NIH [U01 GM092676, P01 GM116691, N01-HD-9-0011/HHSN275200900011C, N01-DK-7-0004/HHSN267200700004C]

向作者/读者索取更多资源

The major objective of this study was to investigate the association of genetic and nongenetic factors with variability in protein abundance and in vitro activity of the androgen-metabolizing enzyme UGT2B17 in human liver microsomes (n = 455). UGT2B17 abundance was quantified by liquid chromatography-tandem mass spectrometry proteomics, and enzyme activity was determined by using testosterone and dihydrotestosterone as in vitro probe substrates. Genotyping or gene resequencing and mRNA expression were also evaluated. Multivariate analysis was used to test the association of UGT2B17 copy number variation, single nucleotide polymorphisms (SNPs), age, and sex with its mRNA expression, abundance, and activity. UGT2B17 gene copy number and SNPs (rs7436962, rs9996186, rs28374627, and rs4860305) were associated with gene expression, protein levels, and androgen glucuronidation rates in a gene dose-dependent manner. UGT2B17 protein (mean +/- S.D. picomoles per milligram of microsomal protein) is sparsely expressed in children younger than 9 years (0.12 +/- 0.24 years) but profoundly increases from age 9 years to adults (similar to 10-fold) with similar to 2.6-fold greater abundance in males than in females (1.2 vs. 0.47). Association of androgen glucuronidation with UGT2B15 abundance was observed only in the low UGT2B17 expressers. These data can be used to predict variability in the metabolism of UGT2B17 substrates. Drug companies should include UGT2B17 in early pheno-typing assays during drug discovery to avoid late clinical failures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据